Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
    6.
    发明申请
    Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers 有权
    用于治疗线粒体疾病和其他条件的氧化还原活性治疗剂和能量生物标志物的调节

    公开(公告)号:US20060281809A1

    公开(公告)日:2006-12-14

    申请号:US11445582

    申请日:2006-06-01

    摘要: Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), or Kearns-Sayre Syndrome (KSS) are disclosed, as well as compounds useful in the methods of the invention, such as alpha-tocopherol quinone. Methods and compounds useful in treating other disorders are also disclosed. Energy biomarkers useful in assessing the metabolic state of a subject and the efficacy of treatment are also disclosed. Methods of modulating, normalizing, or enhancing energy biomarkers, as well as compounds useful for such methods, are also disclosed.

    摘要翻译: 公开了治疗或抑制线粒体疾病如弗里德里希共济失调(FRDA),莱伯氏遗传性视神经病变(LHON),线粒体肌病,脑病,乳酸脱落症,中风(MELAS)或Kearns-Sayre综合征(KSS)的方法,以及 可用于本发明方法的化合物,例如α-生育酚醌。 还公开了可用于治疗其它疾病的方法和化合物。 还公开了可用于评估受试者的代谢状态和治疗功效的能量生物标志物。 还公开了调节,归一化或增强能量生物标志物的方法以及可用于这些方法的化合物。

    1H-Pyrrolo [2, 3 -B] Pyridine Derivatives and Their Use as Radical Quenchers
    8.
    发明申请
    1H-Pyrrolo [2, 3 -B] Pyridine Derivatives and Their Use as Radical Quenchers 有权
    1H-吡咯并[2,3-b]吡啶衍生物及其用作自由基猝灭剂

    公开(公告)号:US20150011580A1

    公开(公告)日:2015-01-08

    申请号:US14371579

    申请日:2013-02-11

    IPC分类号: C07D471/04

    CPC分类号: C07D471/04

    摘要: The present disclosure provides biologically active compounds of formula (I): and pharmaceutically acceptable salts thereof, compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased mitochondrial function resulting in diminished ATP production and/or oxidative stress and/or lipid peroxidation.

    摘要翻译: 本公开提供了式(I)的生物活性化合物及其药学上可接受的盐,包含这些化合物的组合物,以及在各种应用中使用这些化合物的方法,例如治疗或抑制与降低的线粒体功能相关的疾病,导致 减少ATP产生和/或氧化应激和/或脂质过氧化。